Semaglutide patent expiry in 2026 will intensify competition, with Chinese firms launching biosimilars, potentially lowering prices through volume-based procurement
Consequently the researchers posited that " GHSs increase body fat by GH-independent mechanisms that may include increased feeding
The more serious concerns, like pancreatitis or gallbladder issues, are rare
While it is not a first-line treatment, it may be used in functional medicine as part of a broader plan that includes diet, lifestyle changes, and stress management, especially when heavy metal exposure is a contributing factor
It is important not to stop Rybelsus abruptly without medical guidance, as this may lead to deterioration in blood glucose control
Mechanisms of Autoantibody-Induced Pathology